Companies / General Biotechnologies
General Biotechnologies
San Francisco, United States
General Biotechnologies manufactures peptide therapeutics at a fraction of the current cost by genetically programming edible microbes to synthesise complex molecules.
General Biotechnologies, based in San Francisco, United States, has 4 investors on file, among them Axel Ventures, Cartography Capital and Evolution VC Partners. Its latest round on record is Round, 20 Jul 2026. Its site was last checked 13 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get General Biotechnologies and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Axel Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/general.bio/investors
# also
GET /v1/companies/general.bio
GET /v1/companies/general.bio/news